ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells

Zhang, Jian; Yang, Sheng; Guan, Hongmei; Zhou, Jueyu*; Gao, Yuan*南方医科大学; 1; y
Journal of Cellular and Molecular Medicine2021-2DOI: 10.1111/jcmm.16271
8被引8阅读
引用收藏
分享

摘要

Xanthatin (Xa) is a bicyclic sesquiterpene lactone identified from the plant Xanthium L. with impressive antitumor activity, but the role of Xa in non-small cell lung cancer (NSCLC) is not known. Here we found that Xa inhibits proliferation, migration, invasion and induces apoptosis in NSCLC cells. RNA sequencing and Gene set enrichment analysis revealed that Xa significantly activates p53 pathway and suppresses E2F targets, G2M checkpoint and MYC targets in A549 cells. Among these changed genes, the down-regulated gene BARD1 triggered by Xa was identified as a candidate involved in Xa's antitumor effect because of its vital role in homologous recombination (HR). Further studies demonstrated that Xa inhibits HR through the BARD1/BRCA1/RAD51 axis, which enhances cell sensitivity to cisplatin. Mechanistic studies showed that Xa inhibits BARD1 through the JAK2/STAT4 pathway. Our study revealed that Xa is a promising drug to treat NSCLC, especially in combination with conventional chemotherapy.

学科与关键词

关键词
antitumorBARD1cisplatinhomologous recombinationNSCLCXanthatin
相关
加载中…
  • Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis
    Lin, Xian; Liu, Jingfeng; Zou, Yujiao; Tao, Cheng; Chen, Jian*PHYTOMEDICINE, 2022, 105: 154364.被引 10
  • Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis (vol 105, 154364, 2022)
    Lin, Xian; Liu, Jingfeng; Zou, Yujiao; Tao, Cheng; Chen, Jian*PHYTOMEDICINE, 2023, 108: 154547.
  • Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer
    Zhuang, Zhenjie; Huang, Dan; Sheng, Zhou Rui; Jiang, Haimei; Ye, Zeng Jie; Yuan, Yi; Qin, Binyu; Zhao, Yan; Pan, Hua-Feng*; Tang, Ying*PHYTOMEDICINE, 2023, 108: 154491.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2021-02
卷期
第 25 卷, 第 3 期
页码
1688-1699
DOI
10.1111/jcmm.16271
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2015A030313257, 2018A030313392, 2020A1515010308, 2020A1515011278]; National Natural Science Foundation of China [31900886, 81602444, 81972755]

作者

  • Z

    Zhang, Jian (第一作者)

    southern med univ

  • Y

    Yang, Sheng

    southern med univ · 1

查看全部 5 位作者收起作者
  • G

    Guan, Hongmei

    southern med univ

  • Z

    Zhou, Jueyu (通讯)

    southern med univ

  • G

    Gao, Yuan (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417